Prognostic value of CD44 expression in invasive squamous cell carcinoma of the vulva

Gynecologic Oncology

Volumn 75, Issue 1, 1999, Pages 34-40

  Rodríguez Rodríguez, Lorna ^b   Sancho Torres, Inés ^b   Miller Watelet, Luc ^b   Gibbon, Darlene G ^b   Comerci, John T ^b   Mesonero, Clara ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; HERMES ANTIGEN; MESSENGER RNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RNA SPLICING; SQUAMOUS CELL CARCINOMA; TUMOR CELL; VULVA CARCINOMA;

EID: 0344850189     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5560     Document Type: Article

References (25)

1. Bracke M E, Charlier C, Bruyneel E A. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res. 54:1994;4607.
2. Liotta L A, Steeg P S, Stetler-Stevenson W G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327.
3. Underhill C B, Chi-Rosso G, Toole B P. Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells. J Biol Chem. 258:1983;8086-8091.
4. Naor, D, Sionov, R, V, Ish-Shalom, D, CD44: structure, function and association with the malignant process. In, G, F, Vande Woude and G, Klein, (eds), Advances in Cancer Research, San Diego, Academic Press, 1997, 71, pp, 241, - 318.
5. Soukka T, Salmi M, Joensuu H. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res. 57:1997;2281-2289.
6. Teder P, Bergh J, Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not other lung carcinoma cell lines. Cancer Res. 55:1995;3908-3914.
7. Friedrichs K, Folker F, Björn-Wieland L. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res. 55:1995;5424-5433.
8. Rodriguez C, Monges G, Rouanet P. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Int J Cancer. 64:1995;347-354.
9. Li H, Hamou M F, de Tribolet N. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res. 53:1993;5345-5349.
10. Tempfer C, Gitsch G, Haeusler G. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva. Cancer. 78:1996;273-277.
11. Tempfer C, Gitsch G, Hanzal E. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma. Anticancer Res. 16:1996;2029-2032.
12. Ambros R A, Kallakury B V, Malfetano J H. Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response. Int J Gynecol Pathol. 15:1996;320-325.
13. Kainz C, Tempfer C, Kohlberger P, Janisch S, Koelbl H, Gitsch G, Breitenecker G. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Int J Cancer (Pred Oncol). 69:1996;170-173.
14. Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H. Splice variant of CD44 in human cervical cacner stage IB to IIB. Gynecol Oncol. 57:1995;383-387.
15. Shimabukuro K, Toyamo-Sorimachi N, Ozaki Y, Goi T, Furukawa K, Miyasaka M, Aso T. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Gynecol Oncol. 64:1997;26-34.
16. Dellas A, Schultheiss E, Almendral A C. Expression of CD44 and variant isoforms in cervical intraepithelial neoplasia. Gynecol Oncol. 62:1996;218-225.
17. Rodríguez-Rodríguez, L, Sancho-Torres, I, Miller-Watelet, L, Comerci, J, T, Gibbon, D, G, Mesonero, C, CD44-9v and CD44-10v are potential molecular markers for squamous cell carcinoma of the vulva, J Soc Gynecol Invest, submitted.
18. Sturgeon S R, Brinton L A, Devesa S S. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 166:1992;1482.
19. Rodriguez-Rodriguez L, Sancho-Torres I, Mesonero C. CD44 splice variant expression in clear cell carcinoma of the ovary. J Gynecol Oncol. 71:1998;223-229.
20. Gibbon D G, Sancho-Torres I, Mesonero C, Leakey P, Ludlow J W, Rodríguez-Rodríguez L. CD44 splice variants expression correlates with in vitro metastatic potential in ovarian cancer cell lines. J Soc Gynecol Invest. 5:1998;76A.
21. Aruffo A, Stamenkovic I, Melnick M, Underhill C D, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
22. Simon J C, Heider K H, Dietrich A, Wuttig C, Schöpf E, Adolf G R, Ponta H, Herrlich P. Expression of CD44 isoforms in human skin cancer. Eur J Cancer. 32A:1996;1394-1400.
23. Herold-Mende C, Seiter S, Born A I, Patzelt E, Schupp M, Zöller J, Bosch F X, Zöller M. Expression of CD44 splice variants in squamous pithelia and squamous cell carcinomas of the head and neck. J Pathol. 179:1996;66-73.
24. Roye G D, Myers R B, Brown D, Poczatek R, Beenken S W, Grizzle W E. CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int J Cancer (Pred Oncol). 69:1996;254-258.
25. Piffkò J, Bànkfalvi A, Klauke K, Dreier R, Joss U, Böcker W, Schmid K W. Unaltered strong immunohistochemical expression of CD44-v6 and -v5 isoforms during development and progression of oral squamous cell carcinomas. J Oral Pathol Med. 25:1996;502-506.